• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SV-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Pain (1994); Urinary Frequency (2275); Unspecified Kidney or Urinary Problem (4503)
Event Date 05/01/2023
Event Type  Injury  
Manufacturer Narrative
Block b3: the exact date of the event is unknown.The provided event date, (b)(6) 2023, was chosen as the best estimate based on the date that the manufacturer became aware of the event, (b)(6) 2023.Blocks d4 and h4: the complainant was unable to report the lot number; therefore, the manufacture date and expiration date are unknown.Block h6: patient code (b)(6) captures the reportable event of abscess.Patient code (b)(6) captures the reportable event of urinary frequency.Patient code (b)(6) captures the reportable event of pain.
 
Event Description
It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue implant procedure on an unknown date.After the procedure the patient was reported to be doing "ok".The patient started radiation treatment, but on the first day one of the three visicoils seemed to have shifted.The patient's anatomy kept changing.Therefore, the patient's simulation imaging was repeated.Then after three weeks of treatment the patient started to get abdominal pain and went in for a scan that showed the hydrogel was surrounded by a large fluid collection suggestive of a pelvic abscess.Computed tomography (ct) indicated possible tract to rectum.A colorectal surgery did a sigmoidoscopy, the imaging did not show anything in the rectum indicating a fistula.The patient experienced severe thickening of urinary bladder.The physician reported his concerning regarding a cystitis.The patient physician decided not to drain it and prescribed him antibiotics.It was suggested to the patient's physician to drain the active abscess and if is not possible to drain, then the patient may need a surgical excision.The patient reported that "he felt so ill to go outside his house".It was also reported the patient was doing "poorly" at the time of this report.No further information has been obtained despite good faith efforts.
 
Event Description
It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue implant procedure on an unknown date.After the procedure the patient was reported to be doing "ok".The patient started radiation treatment, but on the first day one of the three visicoils seemed to have shifted.The patient's anatomy kept changing.Therefore, the patient's simulation imaging was repeated.Then after three weeks of treatment the patient started to get abdominal pain and went in for a scan that showed the hydrogel was surrounded by a large fluid collection suggestive of a pelvic abscess.Computed tomography (ct) indicated possible tract to rectum.A colorectal surgery did a sigmoidoscopy, the imaging did not show anything in the rectum indicating a fistula.The patient experienced severe thickening of urinary bladder.The physician reported his concerning regarding a cystitis.The patient physician decided not to drain it and prescribed him antibiotics.It was suggested to the patient's physician to drain the active abscess and if is not possible to drain, then the patient may need a surgical excision.The patient reported that "he felt so ill to go outside his house".It was also reported the patient was doing "poorly" at the time of this report.No further information has been obtained despite good faith efforts.Additional information received on june 22, 2023.It was further reported that the procedure was performed under local anesthesia, one day in (b)(6) 2023.
 
Manufacturer Narrative
Additional information block b5 has been updated based on additional information received june 22, 2023.Block b3: the exact date of the event is unknown.The provided event date, may 01, 2023, was chosen as the best estimate based on the date that the manufacturer became aware of the event, may 30, 2023.Blocks d4 and h4: the complainant was unable to report the lot number; therefore, the manufacture date and expiration date are unknown.Block h6: patient code e172001 captures the reportable event of abscess.Patient code e1311 captures the reportable event of unspecific kidney or urinary problem.Patient code e2330 captures the reportable event of pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR VUE SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17175885
MDR Text Key317633324
Report Number3005099803-2023-03274
Device Sequence Number1
Product Code OVB
UDI-Device Identifier00086461000140
UDI-Public0086461000140
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182971
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSV-2101
Device Catalogue NumberSV-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/30/2023
Initial Date FDA Received06/21/2023
Supplement Dates Manufacturer Received06/22/2023
Supplement Dates FDA Received07/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
-
-